On September 23, 2020, Silverback Therapeutics, Inc. closed the transaction. The company has raised over $215,000,000 in funding till date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.33 USD | +7.24% | +12.95% | +70.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.26% | 904M | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- Silverback Therapeutics, Inc. announced that it has received $84.999996 million in funding from a group of investors